Anti-hepatitis B core positivity as a risk factor for hepatocellular carcinoma in alcoholic cirrhosis: A case-control study
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kwon, Oh Sang | - |
dc.contributor.author | Jung, Young Kul | - |
dc.contributor.author | Bae, Kyoung Suk | - |
dc.contributor.author | Kim, Ju Hyun | - |
dc.contributor.author | Kim, Sang Gyune | - |
dc.contributor.author | Kim, Young Seok | - |
dc.contributor.author | Lee, Jung Il | - |
dc.contributor.author | Lee, Jin Woo | - |
dc.contributor.author | Kim, Yun Soo | - |
dc.date.available | 2020-02-29T05:43:49Z | - |
dc.date.created | 2020-02-06 | - |
dc.date.issued | 2012-09 | - |
dc.identifier.issn | 0741-8329 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/16196 | - |
dc.description.abstract | Hepatocellular carcinoma (HCC) is occasionally developed in patients with alcoholic cirrhosis. Old age, male gender, lifetime quantity of alcohol, and presence of hepatitis C virus (HCV) infection are risk factors for HCC in alcoholic cirrhosis. In this study, we investigated whether anti-hepatitis B core (HBc) positivity or occult hepatitis B virus (HBV) infection is a risk factor for HCC in patients with alcoholic cirrhosis. Between January 2006 and August 2008, a total of 72 cirrhotic male patients with an initial diagnosis of HCC, hospitalized in three major hospitals in the lncheon area, were enrolled as cases. Another 72 cirrhotic male patients without HCC, who matched the cases by age (+/- 3 years), were enrolled as controls. All cases and controls were negative for hepatitis B surface antigen and anti-HCV, but had history of chronic alcohol intake over 80 g per day. The clinical characteristics including presence of antiHBc or serum HBV DNA (identified by nested polymerase chain reaction) were investigated. The mean age of both the cases and controls was 62 +/- 10 years. The basal laboratory data, Child-Pugh scores, total lifetime alcohol intake (1459 +/- 1364 versus 1641 +/- 1045 kg), and detection rates of serum HBV DNA [31.7% (20/63) versus 29.9% (20/67)] of the cases and controls were not significantly different. However, the anti-HBc positivity rate was higher among the cases [86.1% (62/72)] than in the controls [66.7% (48/72); p =0.005] and was the only significant risk factor for HCC (odds ratio; 3.1, 95% confidence interval; 1.354-7.098, p = 0.007). Anti-HBc positivity was identified as a risk factor for the development of HCC in patients with alcoholic cirrhosis. (c) 2012 Elsevier Inc. All rights reserved. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | ELSEVIER SCIENCE INC | - |
dc.relation.isPartOf | ALCOHOL | - |
dc.subject | SURFACE-ANTIGEN | - |
dc.subject | VIRUS-INFECTION | - |
dc.subject | C VIRUS | - |
dc.subject | VIRAL-HEPATITIS | - |
dc.subject | OCCULT | - |
dc.subject | DNA | - |
dc.subject | INVOLVEMENT | - |
dc.subject | CONSUMPTION | - |
dc.subject | ANTIBODIES | - |
dc.subject | CLEARANCE | - |
dc.title | Anti-hepatitis B core positivity as a risk factor for hepatocellular carcinoma in alcoholic cirrhosis: A case-control study | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000307864800004 | - |
dc.identifier.doi | 10.1016/j.alcohol.2012.03.006 | - |
dc.identifier.bibliographicCitation | ALCOHOL, v.46, no.6, pp.537 - 541 | - |
dc.identifier.scopusid | 2-s2.0-84864526818 | - |
dc.citation.endPage | 541 | - |
dc.citation.startPage | 537 | - |
dc.citation.title | ALCOHOL | - |
dc.citation.volume | 46 | - |
dc.citation.number | 6 | - |
dc.contributor.affiliatedAuthor | Kwon, Oh Sang | - |
dc.contributor.affiliatedAuthor | Jung, Young Kul | - |
dc.contributor.affiliatedAuthor | Bae, Kyoung Suk | - |
dc.contributor.affiliatedAuthor | Kim, Ju Hyun | - |
dc.contributor.affiliatedAuthor | Kim, Yun Soo | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | Alcoholic cirrhosis | - |
dc.subject.keywordAuthor | Case-control study | - |
dc.subject.keywordAuthor | Hepatitis B core | - |
dc.subject.keywordAuthor | Hepatocellular carcinoma | - |
dc.subject.keywordAuthor | Risk factor | - |
dc.subject.keywordPlus | SURFACE-ANTIGEN | - |
dc.subject.keywordPlus | VIRUS-INFECTION | - |
dc.subject.keywordPlus | C VIRUS | - |
dc.subject.keywordPlus | VIRAL-HEPATITIS | - |
dc.subject.keywordPlus | OCCULT | - |
dc.subject.keywordPlus | DNA | - |
dc.subject.keywordPlus | INVOLVEMENT | - |
dc.subject.keywordPlus | CONSUMPTION | - |
dc.subject.keywordPlus | ANTIBODIES | - |
dc.subject.keywordPlus | CLEARANCE | - |
dc.relation.journalResearchArea | Substance Abuse | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalResearchArea | Toxicology | - |
dc.relation.journalWebOfScienceCategory | Substance Abuse | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Toxicology | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.